April 25, 2025

FDA Approves Penpulimab-kcqx for NPC

The FDA approved penpulimab-kcqx for first line and previously treated recurrent or metastatic non-keratinizing nasopharyngeal carcinoma.

Conexiant

April 24, 2025

Vitamin D Multifaceted CRC Immunomodulator Revealed

"Vitamin D enhances immune organ functions such as the spleen and lymph nodes, and boosts T-cell activity, which is essential in defending the body against tumors."

Conexiant

April 24, 2025

ASCO Updates Guideline for Fertility Preservation in People With Cancer

ASCO has released an update to the guideline for fertility preservation in people with cancer. The update, recently published in the Journal of Clinical Oncology,1 provides recommendations regarding e...

The ASCO Post

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 22, 2025

Heavy Metals Found in Toothpaste

There are some "heavy metals that are essential in small quantities but could result in adverse effects if present in excess."

Conexiant

April 15, 2025

Link Between CT Scans and Future Cancer Incidence?

At current use and radiation dose levels, CT scans may eventually account for 5% of all cancers annually, according to a recent modeling study. The danger is greatest for infants, followed by children...

The ASCO Post

April 10, 2025

Study: LLMs Show Biases in Medical Decision-Making

Large language models recommend different care based on patients' race, housing status, income level, and sexual orientation, potentially amplifying health care disparities if deployed without safeguards, researchers find.

Conexiant

April 09, 2025

Dual Immunotherapy Approved for Advanced CRC

The FDA approved nivolumab with ipilimumab for unresectable or metastatic microsatellite instability–high or mismatch repair–deficient colorectal cancer.

Conexiant

April 09, 2025

Rescue Therapy for Newly Diagnosed High-Grade Osteosarcoma

Could adding higher-dose ifosfamide to methotrexate, doxorubicin, and cisplatin improve outcomes for patients with newly diagnosed high-grade osteosarcoma who responded poorly to neoadjuvant chemother...

The ASCO Post